Company: INMB
Filing Date: 2025-04-21
Form Type: DEF 14A
Source: 0001213900-25-033742
Chunk: 16

Company: Inmune Bio, Inc.
Filing Date: 2025-04-21
Form: DEF 14A
Chunk 16
---
 increase the shares authorized by 2,500,000 shares from 4,000,000 shares to 6,500,000 shares. With these grants and approvals, as of May 28, 2025, the Company will have 2,521,243 awards available to be issued. The Board of Directors determined to increase the number of shares of common stock reserved and available for issuance under the 2021 Plan by 2,500,000 shares because it believes that the current number is insufficient for the purposes of future issuances. The Second Amended and Restated 2021 Plan will result in (i) an increase in the total number of shares of common stock reserved for issuance and (ii) the Committee (as defined below) with the discretion to accelerate vesting of awards upon a Change of Control. This will provide the Company with the ability to grant more awards than are currently available to eligible recipients including employees, directors, consultants and advisors and allow necessary flexibility for such awards. The issuance in the future of awards under the Second Amended and Restated 2021 Plan consisting of full value awards and options to purchase shares of common stock may have the effect of diluting the earnings per share and book value per share, as well as the stock ownership and voting rights, of the holders of the currently outstanding shares of common stock. The effective increase in the number of authorized but unissued shares of common stock which may be issued as awards under the Second Amended and Restated 2021 Plan may be construed as having an anti -takeovereffect by permitting the issuance of shares to purchasers who might oppose a hostile takeover bid or oppose any efforts to amend or repeal certain provisions of the Articles of Incorporation or Bylaws. Holders of the common stock have no preemptive or other subscription rights. There are no other material differences to the 2021 Plan as a result of the Plan Amendment, except as mentioned herein. Material Terms of the Second Amended and Restated 2021 Plan This summary, however, does not purport to be a complete description of all provisions of the Second Amended and Restated 2021 Plan and is qualified in its entirety by reference to the Second Amended and Restated 2021 Plan. Administration.The authority to manage the operation of and administer the Second Amended and Restated 2021 Plan shall be vested in a committee (the “Committee”). The Committee shall be selected by the Board of Directors, and shall consist solely of two or more members of the